Inventor · disambiguated record
Steven J. Shire
Also filed as: SHIRE STEVEN J
20 granted patents·16 pending applications·3,108 citations·filing 1984–2019
97Inventor score
Top patents by PatentIndex Score
36 records- 0198US8142776B2Reduced-viscosity concentrated protein formulationsLIU JUN·Filed 2006·Granted Mar 27, 2012·85 cites·30 claims
- 0298US7682609B2Protein formulationGENENTECH INC·Filed 2006·Granted Mar 23, 2010·77 cites·30 claims
- 0398US7666413B2Method of reducing viscosity of high concentration protein formulationsGENENTECH INC·Filed 2005·Granted Feb 23, 2010·103 cites·21 claims
- 0498US6875432B2Reduced-viscosity concentrated protein formulationsGENENTECH INC·Filed 2001·Granted Apr 5, 2005·316 cites·59 claims
- 0598US6685940B2Protein formulationGENENTECH INC·Filed 2001·Granted Feb 3, 2004·402 cites·15 claims
- 0698US6267958B1Protein formulationGENENTECH INC·Filed 1996·Granted Jul 31, 2001·1.5k cites·47 claims
- 0797US8961964B2High concentration antibody and protein formulationsLIU JUN·Filed 2011·Granted Feb 24, 2015·45 cites·14 claims
- 0897US8703126B2Reduced-viscosity concentrated protein formulationsLIU JUN·Filed 2011·Granted Apr 22, 2014·56 cites·24 claims
- 0997US4512922APurification and activity assurance of precipitated heterologous proteinsGENENTECH INC·Filed 1984·Granted Apr 23, 1985·334 cites·9 claims
- 1096US10034940B2High concentration antibody and protein formulationsGENENTECH INC·Filed 2015·Granted Jul 31, 2018·19 cites·24 claims
- 1195US9283273B2Protein formulationANDYA JAMES·Filed 2012·Granted Mar 15, 2016·20 cites·16 claims
- 1293US9180189B2Treating a mammal with a formulation comprising an antibody which binds IgEANDYA JAMES·Filed 2005·Granted Nov 10, 2015·18 cites·4 claims
- 1390US10166293B2Reduced-viscosity concentrated protein formulationsGENENTECH INC·Filed 2014·Granted Jan 1, 2019·9 cites·58 claims
- 1483US5279823APurified forms of DNASEGENENTECH INC·Filed 1992·Granted Jan 18, 1994·41 cites·8 claims
- 1582US6440412B1Purified forms of DNaseGENENTECH INC·Filed 2000·Granted Aug 27, 2002·10 cites·4 claims
- 1680US5945402AHuman relaxin formulationGENENTECH INC·Filed 1995·Granted Aug 31, 1999·30 cites·16 claims
- 1768US5451572AHuman relaxin formulationGENENTECH INC·Filed 1993·Granted Sep 19, 1995·28 cites·25 claims
- 1868US2019358323A1High concentration antibody and protein formulationsGENENTECH INC·Filed 2019·Application pending·0 cites
- 1967US2009280129A1High concentration antibody and protein formulationsGENENTECH INC·Filed 2008·Application pending·0 cites
- 2065US2010158898A1METHODS OF TREATING IgE-MEDIATED DISORDERS COMPRISING THE ADMINISTRATION OF HIGH CONCENTRATION ANTI-IgE ANTIBODY FORMULATIONSGENENTECH INC·Filed 2009·Application pending·0 cites
- 2162US2019231875A1Reduced-viscosity concentrated protein formulationsGENENTECH INC·Filed 2018·Application pending·0 cites
- 2262US2007053900A1High concentration antibody and protein formulationsGENENTECH INC·Filed 2006·Application pending·0 cites
- 2361US2017049888A1High concentration antibody and protein formulationsGENENTECH INC·Filed 2016·Application pending·0 cites
- 2461US2009087426A1Methods for Treatment of Allergic AsthmaGENENTECH INC·Filed 2008·Application pending·0 cites
- 2559US2011236383A1Protein FormulationANDYA JAMES·Filed 2011·Application pending·0 cites
- 2659US2004197324A1High concentration antibody and protein formulationsGENENTECH INC·Filed 2004·Application pending·0 cites
- 2758US2010158899A1Protein formulationGENENTECH INC·Filed 2010·Application pending·0 cites
- 2857US2005158303A1Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulationsNOVARTIS AG·Filed 2004·Application pending·0 cites
- 2957US2007086995A1Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulationsGENENTECH INC·Filed 2006·Application pending·0 cites
- 3056US2007020256A1Methods for treatment of allergic asthmaGENENTECH INC·Filed 2006·Application pending·0 cites
- 3155US2016367675A1Reduced-viscosity concentrated protein formulationsGENENTECH INC·Filed 2016·Application pending·0 cites
- 3253US2004197326A1Method for treatment of allergic asthmaGENENTECH INC·Filed 2004·Application pending·0 cites
- 3350US2011311520A1Methods for treatment of allergic asthmaFICK ROBERT B·Filed 2011·Application pending·0 cites
- 3449US7018825B2DNase liquid solutionsGENENTECH INC·Filed 2002·Granted Mar 28, 2006·0 cites·17 claims
- 3542US6932965B2Purified forms of DNaseGENENTECH INC·Filed 2002·Granted Aug 23, 2005·3 cites·6 claims
- 3635US6383788B1Minimizing thermally induced aggregation of DNase in solution with calciumGENENTECH INC·Filed 1995·Granted May 7, 2002·4 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Steven J. Shire files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →